Samjin Pharmaceuticals Co., Ltd. (005500.KS) KSC

Currency In KRW

AD

Valuation

Market Cap241.98B
Enterprise Value365.79B
P/E Ratio9.86
PEG Ratio0.59
Price/Sales Ratio0.75
Price/Book Ratio0.78
Enterprise/Revenue1.13
Enterprise/EBITDA18.3

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.07
Operating Margin0.07
AD

Management Effectiveness

Return On Assets0.05
Return On Equity0.08

Income Statement

Revenue309.13B
Revenue/Share24,598.47
Gross Profit153.03B
EBITDA44.5B
Net Income24.17B
Diluted EPS1,962.68

Balance Sheet

Total Cash20.88B
Total Cash/Share1,649.21
Total Debt129.88B
Total Debt/Equity0.43
Current Ratio1.32
Book Value Per Share23,684.05

Price History

52-Week Change-3.81
52-Week High25,900
52-Week Low16,580
Moving Average 50 Days18,164.2
Moving Average 200 Days19,042.9

Statistics

Average Volume53,097
Shares Outstanding12.66M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate800
Trailing Annual Dividend Yield4.34
Payout Ratio0.44
Last Split Factor1031:1000
Last Split DateDecember 29, 2010
AD